MORPHOLOGICAL ASPECTS OF CHEMOTHERAPY-RESISTANT OVARIAL CARCINOMAS

被引:0
|
作者
BURGER, H
LOCHER, GW
DREHER, E
BURKI, K
DAVIS, B
GOLDHIRSCH, A
机构
[1] UNIV BERN,LUDWIG INST KREBSFORSCH,FRAUENKLIN,CH-3000 BERN,SWITZERLAND
[2] UNIV BERN,LUDWIG INST KREBSFORSCH,INST PATHOL,CH-3000 BERN,SWITZERLAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:757 / 758
页数:2
相关论文
共 50 条
  • [1] CHEMOTHERAPY OF OVARIAL CARCINOMAS
    PFLEIDERER, A
    [J]. STRAHLENTHERAPIE, 1982, 158 (12) : 708 - 716
  • [2] Chemotherapy-Resistant Metastatic Breast Cancer
    Marquette, Carrie
    Nabell, Lisle
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 263 - 275
  • [3] Management of chemotherapy-resistant breast cancer
    Miles, DW
    Rubens, RD
    [J]. BREAST, 1996, 5 (04): : 288 - 292
  • [4] Chemotherapy-Resistant T Cells.
    Turtle, Cameron J.
    [J]. BLOOD, 2010, 116 (21) : 1767 - 1767
  • [5] Chemotherapy-Resistant Metastatic Breast Cancer
    Carrie Marquette
    Lisle Nabell
    [J]. Current Treatment Options in Oncology, 2012, 13 : 263 - 275
  • [6] Advances in chemotherapy-resistant hepatocellular carcinoma
    Liu, Shui
    Li, Qiao
    Li, Yongzhi
    Sheng, Jiyao
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [7] Compound kills chemotherapy-resistant glioblastoma cells
    Sarah Lemprière
    [J]. Nature Reviews Neurology, 2019, 15 : 620 - 621
  • [8] Biomodulatory approaches to chemotherapy-resistant breast cancer
    Mitchell, MS
    [J]. BREAST, 1996, 5 (04): : 323 - 329
  • [9] Hur inhibition is a novel approach to treatment of chemotherapy-resistant low-grade serous ovarian carcinomas
    Dandulakis, M.
    Reader, J.
    Smith, P.
    Fan, C.
    Carey, M. S.
    Lin, J.
    Xu, L.
    Legesse, T.
    Rao, G. G.
    Fulton, A.
    Roque, D. M.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 122 - 122
  • [10] TARGETING CHEMOTHERAPY-RESISTANT AML STEM CELLS
    Ishikawa, F.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 61 - 62